Excessive ROS production has been shown to drive inflammation (74), and the activation of the NLRP3 inflammasome through ROS plays a key role in the progression of NASH (75, 76). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.